Dr. Kumar Belani’s study comparing the effects Roux-en-Y gastric bypass vs. intensive medical management in achieving remission of type 2 diabetes mellitus was recently featured in Obesity Surgery. Trials were conducted at four teaching hospitals involving 71 total participants in both the United States and Taiwan. The study found that after 24 months weight loss was greater in the RYGB group in both populations than in the IMM group. In the RYGB group, a substantial proportion of the subjects achieved complete or partial remission. This was the first randomized controlled trial enrolling both Taiwanese and Americans comparing RYGB to a lifestyle intervention control group.
Read the complete study.